$LGND
LIGAND PHARMACEUTICALS INC

2019 Q2 Form 10-Q Financial Statement

#000088616319000156 Filed on August 08, 2019

View on sec.gov

Income Statement

Concept 2019 Q2 2018 Q2
Revenue $24.99M $90.04M
YoY Change -72.25% 221.64%
Cost Of Revenue $2.405M $1.134M
YoY Change 112.08% 25.58%
Gross Profit $22.58M $88.91M
YoY Change -74.6% 228.17%
Gross Profit Margin 90.37% 98.74%
Selling, General & Admin $10.99M $9.290M
YoY Change 18.3% 41.83%
% of Gross Profit 48.67% 10.45%
Research & Development $12.21M $6.135M
YoY Change 99.07% 27.23%
% of Gross Profit 54.08% 6.9%
Depreciation & Amortization $3.700M $3.000M
YoY Change 23.33% 15.38%
% of Gross Profit 16.38% 3.37%
Operating Expenses $12.21M $6.135M
YoY Change 99.07% 27.23%
Operating Profit -$4.130M $70.18M
YoY Change -105.89% 439.19%
Interest Expense $9.012M $13.45M
YoY Change -33.02% 302.69%
% of Operating Profit 19.17%
Other Income/Expense, Net -$13.90M $25.40M
YoY Change -154.71% -638.79%
Pretax Income -$18.03M $95.58M
YoY Change -118.86% 1051.55%
Income Tax -$3.609M $22.42M
% Of Pretax Income 23.46%
Net Earnings -$14.42M $73.16M
YoY Change -119.71% 0.0%
Net Earnings / Revenue -57.71% 81.25%
Basic Earnings Per Share -$0.74 $3.45
Diluted Earnings Per Share -$0.74 $2.99
COMMON SHARES
Basic Shares Outstanding 19.56M shares 21.21M shares
Diluted Shares Outstanding 19.56M shares 24.44M shares

Balance Sheet

Concept 2019 Q2 2018 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.392B $1.017B
YoY Change 36.95% 489.05%
Cash & Equivalents $273.0M $151.5M
Short-Term Investments $1.119B $865.3M
Other Short-Term Assets $5.672M $12.82M
YoY Change -55.75% 1095.62%
Inventory $9.638M $9.520M
Prepaid Expenses
Receivables $20.30M $42.00M
Other Receivables $0.00 $0.00
Total Short-Term Assets $1.442B $1.480B
YoY Change -2.58% 650.83%
LONG-TERM ASSETS
Property, Plant & Equipment $6.268M $4.187M
YoY Change 49.7% 123.31%
Goodwill $88.00M $85.96M
YoY Change 2.37% 19.05%
Intangibles $212.6M $222.0M
YoY Change -4.23% 11.4%
Long-Term Investments $60.38M $0.00
YoY Change -100.0%
Other Assets $1.680M $642.0K
YoY Change 161.68% -61.51%
Total Long-Term Assets $359.5M $377.8M
YoY Change -4.84% -14.69%
TOTAL ASSETS
Total Short-Term Assets $1.442B $1.480B
Total Long-Term Assets $359.5M $377.8M
Total Assets $1.802B $1.858B
YoY Change -3.04% 190.35%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.888M $2.682M
YoY Change 7.68% 49.08%
Accrued Expenses $11.54M $9.312M
YoY Change 23.93% 74.87%
Deferred Revenue $939.0K $1.700M
YoY Change -44.76%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $27.10M $210.4M
YoY Change -87.12% -3.75%
Total Short-Term Liabilities $109.0M $632.9M
YoY Change -82.78% 180.22%
LONG-TERM LIABILITIES
Long-Term Debt $624.2M $595.9M
YoY Change 4.75% 2352.26%
Other Long-Term Liabilities $7.692M $1.563M
YoY Change 392.13% 70.82%
Total Long-Term Liabilities $7.692M $1.563M
YoY Change 392.13% 70.82%
TOTAL LIABILITIES
Total Short-Term Liabilities $109.0M $632.9M
Total Long-Term Liabilities $7.692M $1.563M
Total Liabilities $760.4M $1.238B
YoY Change -38.6% 437.03%
SHAREHOLDERS EQUITY
Retained Earnings $422.7M -$254.2M
YoY Change -266.27% -36.81%
Common Stock $19.00K $21.00K
YoY Change -9.52% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.041B $619.8M
YoY Change
Total Liabilities & Shareholders Equity $1.802B $1.858B
YoY Change -3.04% 190.35%

Cashflow Statement

Concept 2019 Q2 2018 Q2
OPERATING ACTIVITIES
Net Income -$14.42M $73.16M
YoY Change -119.71% 0.0%
Depreciation, Depletion And Amortization $3.700M $3.000M
YoY Change 23.33% 15.38%
Cash From Operating Activities -$61.10M $73.60M
YoY Change -183.02% 377.92%
INVESTING ACTIVITIES
Capital Expenditures -$200.0K
YoY Change 100.0%
Acquisitions
YoY Change
Other Investing Activities $265.8M -$586.6M
YoY Change -145.31% -1810.2%
Cash From Investing Activities $265.8M -$586.7M
YoY Change -145.3% -1815.5%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -37.60M 613.6M
YoY Change -106.13%
NET CHANGE
Cash From Operating Activities -61.10M 73.60M
Cash From Investing Activities 265.8M -586.7M
Cash From Financing Activities -37.60M 613.6M
Net Change In Cash 167.1M 100.5M
YoY Change 66.27% 102.62%
FREE CASH FLOW
Cash From Operating Activities -$61.10M $73.60M
Capital Expenditures -$200.0K
Free Cash Flow $73.80M
YoY Change 376.13%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2019
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Entity Central Index Key
EntityCentralIndexKey
0000886163
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2019Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2018Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2019Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
60000000 shares
CY2018Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
60000000 shares
CY2019Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
19390 shares
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
20766 shares
CY2019Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
19390 shares
CY2018Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
20766 shares
CY2019Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2018Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2019Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2018Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2019Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2018Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2019Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2018Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2018Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
2739643 shares
lgnd Lessee Operating Lease Remaining Lease Term
LesseeOperatingLeaseRemainingLeaseTerm
P7Y
CY2019Q2 us-gaap Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
P7Y
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2019-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-33093
dei Entity Registrant Name
EntityRegistrantName
LIGAND PHARMACEUTICALS INCORPORATED
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
77-0160744
dei Entity Address Address Line1
EntityAddressAddressLine1
3911 Sorrento Valley Boulevard, Suite 110
dei Entity Address City Or Town
EntityAddressCityOrTown
San Diego
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
92121
dei City Area Code
CityAreaCode
858
dei Local Phone Number
LocalPhoneNumber
550-7500
dei Security12b Title
Security12bTitle
Common Stock , par value $0.001 per share
dei Trading Symbol
TradingSymbol
LGND
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2019Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
19011474 shares
CY2019Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
273047000 USD
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
117164000 USD
CY2019Q2 us-gaap Short Term Investments
ShortTermInvestments
1059002000 USD
CY2018Q4 us-gaap Short Term Investments
ShortTermInvestments
601217000 USD
CY2019Q2 us-gaap Equity Method Investments
EquityMethodInvestments
60376000 USD
CY2018Q4 us-gaap Equity Method Investments
EquityMethodInvestments
55448000 USD
CY2019Q2 us-gaap Receivables Net Current
ReceivablesNetCurrent
20259000 USD
CY2018Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
55850000 USD
CY2019Q2 us-gaap Inventory Net
InventoryNet
9638000 USD
CY2018Q4 us-gaap Inventory Net
InventoryNet
7124000 USD
CY2019Q2 us-gaap Derivative Assets Current
DerivativeAssetsCurrent
14313000 USD
CY2018Q4 us-gaap Derivative Assets Current
DerivativeAssetsCurrent
22576000 USD
CY2019Q2 us-gaap Other Assets Current
OtherAssetsCurrent
5672000 USD
CY2018Q4 us-gaap Other Assets Current
OtherAssetsCurrent
11161000 USD
CY2019Q2 us-gaap Assets Current
AssetsCurrent
1442307000 USD
CY2018Q4 us-gaap Assets Current
AssetsCurrent
870540000 USD
CY2019Q2 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
0 USD
CY2018Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
46521000 USD
CY2019Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
212609000 USD
CY2018Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
219793000 USD
CY2019Q2 us-gaap Goodwill
Goodwill
88000000 USD
CY2018Q4 us-gaap Goodwill
Goodwill
86646000 USD
CY2019Q2 lgnd Commercial License Rights
CommercialLicenseRights
40008000 USD
CY2018Q4 lgnd Commercial License Rights
CommercialLicenseRights
31460000 USD
CY2019Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
6268000 USD
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5372000 USD
CY2019Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
10964000 USD
CY2018Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
0 USD
CY2019Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1680000 USD
CY2018Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
471000 USD
CY2019Q2 us-gaap Assets
Assets
1801836000 USD
CY2018Q4 us-gaap Assets
Assets
1260803000 USD
CY2019Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
2888000 USD
CY2018Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
4183000 USD
CY2019Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
11540000 USD
CY2018Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
19200000 USD
CY2019Q2 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
47455000 USD
CY2018Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
0 USD
CY2019Q2 lgnd Current Portion Of Liability For Contingent Value Rights
CurrentPortionOfLiabilityForContingentValueRights
4763000 USD
CY2018Q4 lgnd Current Portion Of Liability For Contingent Value Rights
CurrentPortionOfLiabilityForContingentValueRights
5717000 USD
CY2019Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
939000 USD
CY2018Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
3286000 USD
CY2019Q2 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
27087000 USD
CY2018Q4 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
26433000 USD
CY2019Q2 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
14313000 USD
CY2018Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
23430000 USD
CY2019Q2 us-gaap Liabilities Current
LiabilitiesCurrent
108985000 USD
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
82249000 USD
CY2019Q2 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
624209000 USD
CY2018Q4 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
609864000 USD
CY2019Q2 lgnd Liability For Contingent Value Rights
LiabilityForContingentValueRights
8314000 USD
CY2018Q4 lgnd Liability For Contingent Value Rights
LiabilityForContingentValueRights
6825000 USD
CY2019Q2 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
694000 USD
CY2018Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
0 USD
CY2019Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
10489000 USD
CY2018Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
0 USD
CY2019Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
7692000 USD
CY2018Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
951000 USD
CY2019Q2 us-gaap Liabilities
Liabilities
760383000 USD
CY2018Q4 us-gaap Liabilities
Liabilities
699889000 USD
CY2019Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2018Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2019Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2018Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2019Q2 us-gaap Common Stock Value
CommonStockValue
19000 USD
CY2018Q4 us-gaap Common Stock Value
CommonStockValue
21000 USD
CY2019Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
619255000 USD
CY2018Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
791114000 USD
CY2019Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-542000 USD
CY2018Q2 us-gaap Cost Of Goods And Services Sold Amortization
CostOfGoodsAndServicesSoldAmortization
3305000 USD
us-gaap Cost Of Goods And Services Sold Amortization
CostOfGoodsAndServicesSoldAmortization
7008000 USD
CY2018Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1024000 USD
CY2019Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
422721000 USD
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-229197000 USD
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
1041453000 USD
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
560914000 USD
CY2019Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1801836000 USD
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1260803000 USD
CY2019Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
24987000 USD
CY2018Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
90043000 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
68471000 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
146200000 USD
CY2019Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
2405000 USD
CY2018Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1134000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
6263000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1922000 USD
CY2019Q2 us-gaap Cost Of Goods And Services Sold Amortization
CostOfGoodsAndServicesSoldAmortization
3505000 USD
us-gaap Cost Of Goods And Services Sold Amortization
CostOfGoodsAndServicesSoldAmortization
6584000 USD
CY2019Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
12213000 USD
CY2018Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6135000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
23502000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
13540000 USD
CY2019Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10994000 USD
CY2018Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
9294000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
22082000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
16938000 USD
CY2019Q2 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
29117000 USD
CY2018Q2 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
19868000 USD
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
58855000 USD
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
38984000 USD
CY2019Q2 us-gaap Gain Loss On Disposition Of Intangible Assets
GainLossOnDispositionOfIntangibleAssets
0 USD
CY2018Q2 us-gaap Gain Loss On Disposition Of Intangible Assets
GainLossOnDispositionOfIntangibleAssets
0 USD
us-gaap Gain Loss On Disposition Of Intangible Assets
GainLossOnDispositionOfIntangibleAssets
812797000 USD
us-gaap Gain Loss On Disposition Of Intangible Assets
GainLossOnDispositionOfIntangibleAssets
0 USD
CY2019Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-4130000 USD
CY2018Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
70175000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
822413000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
107216000 USD
CY2019Q2 us-gaap Gain Loss On Investments
GainLossOnInvestments
-12365000 USD
CY2018Q2 us-gaap Gain Loss On Investments
GainLossOnInvestments
39963000 USD
us-gaap Gain Loss On Investments
GainLossOnInvestments
4928000 USD
us-gaap Gain Loss On Investments
GainLossOnInvestments
61808000 USD
CY2019Q2 us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
9285000 USD
CY2018Q2 us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
2762000 USD
us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
15194000 USD
us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
3637000 USD
CY2019Q2 us-gaap Interest Expense
InterestExpense
9012000 USD
CY2018Q2 us-gaap Interest Expense
InterestExpense
13454000 USD
us-gaap Interest Expense
InterestExpense
17918000 USD
us-gaap Interest Expense
InterestExpense
16933000 USD
CY2019Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1806000 USD
CY2018Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-3867000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
68000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-4835000 USD
CY2019Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-13898000 USD
CY2018Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
25404000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2272000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
43677000 USD
CY2019Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-18028000 USD
CY2018Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
95579000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
824685000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
150893000 USD
CY2019Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-3609000 USD
CY2018Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
22419000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
172767000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
32452000 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-14419000 USD
CY2018Q2 us-gaap Net Income Loss
NetIncomeLoss
73160000 USD
us-gaap Net Income Loss
NetIncomeLoss
651918000 USD
us-gaap Net Income Loss
NetIncomeLoss
118441000 USD
CY2019Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.74
CY2018Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.45
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
32.60
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
5.58
CY2019Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19558000 shares
CY2018Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
21212000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20000000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
21209000 shares
CY2019Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.74
CY2018Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.99
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
31.34
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
4.81
CY2019Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19558000 shares
CY2018Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
24438000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20799000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
24618000 shares
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-14419000 USD
CY2018Q2 us-gaap Net Income Loss
NetIncomeLoss
73160000 USD
us-gaap Net Income Loss
NetIncomeLoss
651918000 USD
us-gaap Net Income Loss
NetIncomeLoss
118441000 USD
CY2019Q2 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
503000 USD
CY2018Q2 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
135000 USD
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
733000 USD
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-14000 USD
CY2019Q2 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
542000 USD
CY2018Q2 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
0 USD
us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
251000 USD
us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
0 USD
CY2019Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-14458000 USD
CY2018Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
73295000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
652400000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
118427000 USD
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
560914000 USD
CY2019Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-991000 USD
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5347000 USD
CY2019Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
151585000 USD
CY2019Q1 us-gaap Debt Securities Available For Sale Unrealized Gain Loss
DebtSecuritiesAvailableForSaleUnrealizedGainLoss
230000 USD
CY2019Q1 lgnd Adjustments To Additional Paid In Capital Foreign Currency Translation Adjustment
AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment
291000 USD
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
-569000 USD
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
666337000 USD
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
1079974000 USD
CY2019Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
740000 USD
CY2019Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6571000 USD
CY2019Q2 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
33717000 USD
CY2019Q2 us-gaap Debt Securities Available For Sale Unrealized Gain Loss
DebtSecuritiesAvailableForSaleUnrealizedGainLoss
503000 USD
CY2019Q2 lgnd Adjustments To Additional Paid In Capital Foreign Currency Translation Adjustment
AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment
-542000 USD
CY2019Q2 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
2343000 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-14419000 USD
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
1041453000 USD
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
399788000 USD
CY2018Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
5119000 USD
CY2018Q1 us-gaap Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt
AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
2781000 USD
CY2018Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4555000 USD
CY2018Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
1895000 USD
CY2018Q1 us-gaap Debt Securities Available For Sale Unrealized Gain Loss
DebtSecuritiesAvailableForSaleUnrealizedGainLoss
-110000 USD
CY2018Q1 us-gaap Net Income Loss
NetIncomeLoss
45279000 USD
CY2018Q1 us-gaap Stockholders Equity
StockholdersEquity
481100000 USD
CY2018Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
3296000 USD
CY2018Q2 us-gaap Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt
AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
16078000 USD
CY2018Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4812000 USD
CY2018Q2 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
50832000 USD
CY2018Q2 us-gaap Debt Securities Available For Sale Unrealized Gain Loss
DebtSecuritiesAvailableForSaleUnrealizedGainLoss
-495000 USD
CY2018Q2 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
838000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
4928000 USD
CY2018Q2 us-gaap Net Income Loss
NetIncomeLoss
73160000 USD
CY2018Q2 us-gaap Stockholders Equity
StockholdersEquity
619813000 USD
us-gaap Profit Loss
ProfitLoss
651918000 USD
us-gaap Profit Loss
ProfitLoss
118441000 USD
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
812797000 USD
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
0 USD
lgnd Non Cash Change In Estimated Fair Value Of Contingent Value Rights
NonCashChangeInEstimatedFairValueOfContingentValueRights
-984000 USD
lgnd Non Cash Change In Estimated Fair Value Of Contingent Value Rights
NonCashChangeInEstimatedFairValueOfContingentValueRights
-2730000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
8781000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
6013000 USD
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
6023000 USD
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
1150000 USD
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
14999000 USD
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
15455000 USD
lgnd Amortization Of Other Economic Rights
AmortizationOfOtherEconomicRights
4370000 USD
lgnd Amortization Of Other Economic Rights
AmortizationOfOtherEconomicRights
0 USD
us-gaap Share Based Compensation
ShareBasedCompensation
11918000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
61808000 USD
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
-3973000 USD
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
1701000 USD
us-gaap Proceeds From Royalties Received
ProceedsFromRoyaltiesReceived
0 USD
us-gaap Proceeds From Royalties Received
ProceedsFromRoyaltiesReceived
32707000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
9367000 USD
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-55661000 USD
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-32263000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-35591000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
16405000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
4573000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
4395000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-3780000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
80000 USD
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
47455000 USD
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
0 USD
lgnd Increase Decrease In Other Economic Rights
IncreaseDecreaseInOtherEconomicRights
-12000000 USD
lgnd Increase Decrease In Other Economic Rights
IncreaseDecreaseInOtherEconomicRights
0 USD
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
597000 USD
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
-594000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-15800000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
134405000 USD
us-gaap Proceeds From Sale Of Intangible Assets
ProceedsFromSaleOfIntangibleAssets
812797000 USD
us-gaap Proceeds From Sale Of Intangible Assets
ProceedsFromSaleOfIntangibleAssets
0 USD
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
1281274000 USD
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
745783000 USD
us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
43724000 USD
us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
12791000 USD
us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
791006000 USD
us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
110175000 USD
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
5673000 USD
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-2498000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
360580000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-620319000 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
0 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
21785000 USD
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
0 USD
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
750000000 USD
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0 USD
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
16900000 USD
us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
0 USD
us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
90000000 USD
us-gaap Payments For Hedge Financing Activities
PaymentsForHedgeFinancingActivities
0 USD
us-gaap Payments For Hedge Financing Activities
PaymentsForHedgeFinancingActivities
140250000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
2643000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
2893000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
3434000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
11849000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
189917000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
52727000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-190167000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
616753000 USD
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7000 USD
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
154620000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
130839000 USD
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
119780000 USD
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
20620000 USD
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
274400000 USD
CY2018Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
151459000 USD
us-gaap Interest Paid Net
InterestPaidNet
2915000 USD
us-gaap Interest Paid Net
InterestPaidNet
919000 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
69703000 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
285000 USD
CY2019Q2 us-gaap Restricted Cash Current
RestrictedCashCurrent
1353000 USD
CY2018Q2 us-gaap Restricted Cash Current
RestrictedCashCurrent
0 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
54000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
66000 USD
lgnd Accrued Inventory Purchases
AccruedInventoryPurchases
0 USD
lgnd Accrued Inventory Purchases
AccruedInventoryPurchases
752000 USD
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
938000 USD
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
0 USD
us-gaap Debt Instrument Convertible If Converted Value In Excess Of Principal
DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal
0 USD
us-gaap Debt Instrument Convertible If Converted Value In Excess Of Principal
DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal
31571000 USD
lgnd Shares Reacquired In Hedge Transaction Value
SharesReacquiredInHedgeTransactionValue
0 USD
lgnd Shares Reacquired In Hedge Transaction Value
SharesReacquiredInHedgeTransactionValue
31571000 USD
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman';font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Reclassifications</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman';font-size:10pt;font-weight:400;line-height:120%;">Certain amounts in the prior period consolidated financial statements have been reclassified to conform with the current period presentation. Specifically, our investment in Viking warrants was reclassified from “other current assets” to “investment in Viking” in the audited consolidated balance sheet as of December 31, 2018. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman';font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Prior Period Immaterial Error</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman';font-size:10pt;font-weight:400;line-height:120%;">In connection with the preparation of our condensed consolidated statement of cash flows for the six months ended June 30, 2019, an immaterial error was identified in our condensed consolidated statement of cash flows for the three months ended March 31, 2019 by including a $4.6 million accrued liability for the share repurchase as of December 31, 2018 that was paid during the first quarter of 2019 in the cash flows for operating activities instead of financing activities. Our condensed consolidated statement of cash flows for the three months ended March 31, 2019 understated cash flows provided by operating activities by $4.6 million and understated cash flows used in financing activities by $4.6 million. We evaluated the materiality of the error considering both quantitative and qualitative factors as required by authoritative guidance and determined the related impact was not material to our previously issued condensed consolidated financial statements. The immaterial error has been corrected in our condensed consolidated statement of cash flows for the six months ended June 30, 2019. The immaterial error did not impact our condensed consolidated balance sheet as of March 31, 2019, nor did it impact our condensed consolidated statements of operations, comprehensive income or equity for the three months ended March 31, 2019.</span></div>
us-gaap Use Of Estimates
UseOfEstimates
<div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman';font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Use of Estimates</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman';font-size:10pt;font-weight:400;line-height:120%;">The preparation of condensed consolidated financial statements in conformity with GAAP requires the use of estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and the accompanying notes. Actual results may differ from those estimates.</span></div>
CY2019Q2 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
2700000 USD
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
4100000 USD
CY2019Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
24987000 USD
CY2018Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
90043000 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
68471000 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
146200000 USD
CY2019Q2 lgnd Debt Securities Available For Sale And Equity Securities Fvni Amortized Cost
DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNIAmortizedCost
1057454000 USD
CY2019Q2 lgnd Debt Securities Available For Sale And Equity Securities Fvni Accumulated Gross Unrealized Gain Before Tax
DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNIAccumulatedGrossUnrealizedGainBeforeTax
1796000 USD
CY2019Q2 lgnd Debt Securities Available For Sale And Equity Securities Fvni Accumulated Gross Unrealized Loss Before Tax
DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNIAccumulatedGrossUnrealizedLossBeforeTax
248000 USD
CY2019Q2 lgnd Debt Securities Available For Sale And Equity Securities Fvni
DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI
1059002000 USD
CY2018Q4 lgnd Debt Securities Available For Sale And Equity Securities Fvni Amortized Cost
DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNIAmortizedCost
600154000 USD
CY2018Q4 lgnd Debt Securities Available For Sale And Equity Securities Fvni Accumulated Gross Unrealized Gain Before Tax
DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNIAccumulatedGrossUnrealizedGainBeforeTax
1226000 USD
CY2018Q4 lgnd Debt Securities Available For Sale And Equity Securities Fvni Accumulated Gross Unrealized Loss Before Tax
DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNIAccumulatedGrossUnrealizedLossBeforeTax
163000 USD
CY2018Q4 lgnd Debt Securities Available For Sale And Equity Securities Fvni
DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI
601217000 USD
CY2019Q2 us-gaap Goodwill
Goodwill
88000000 USD
CY2018Q4 us-gaap Goodwill
Goodwill
86646000 USD
CY2019Q2 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
300609000 USD
CY2018Q4 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
306439000 USD
CY2019Q2 us-gaap Notes Receivable Fair Value Disclosure
NotesReceivableFairValueDisclosure
50100000 USD
CY2018Q4 us-gaap Notes Receivable Fair Value Disclosure
NotesReceivableFairValueDisclosure
46200000 USD
CY2019Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2856000 USD
CY2018Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
4045000 USD
CY2019Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
738000 USD
CY2018Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
942000 USD
CY2019Q2 us-gaap Interest Payable Current
InterestPayableCurrent
411000 USD
CY2018Q4 us-gaap Interest Payable Current
InterestPayableCurrent
428000 USD
CY2019Q2 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
872000 USD
CY2018Q4 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
1025000 USD
CY2019Q2 lgnd Accrued Broker Fees
AccruedBrokerFees
0 USD
CY2018Q4 lgnd Accrued Broker Fees
AccruedBrokerFees
4613000 USD
CY2019Q2 lgnd Returns Accrual
ReturnsAccrual
3346000 USD
CY2018Q4 lgnd Returns Accrual
ReturnsAccrual
3590000 USD
CY2019Q2 us-gaap Restructuring Reserve
RestructuringReserve
7000 USD
CY2018Q4 us-gaap Restructuring Reserve
RestructuringReserve
1093000 USD
CY2019Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
989000 USD
CY2018Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
0 USD
CY2019Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
2321000 USD
CY2018Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
3464000 USD
CY2019Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
11540000 USD
CY2018Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
19200000 USD
CY2019Q2 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
6571000 USD
CY2018Q2 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
4812000 USD
us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
11918000 USD
us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
9367000 USD
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.019
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.028
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.024
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.028
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.40
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.36
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.43
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.34
CY2019Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y10M24D
CY2018Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y9M18D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y2M12D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y8M12D
CY2019Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
19558000 shares
CY2018Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
21212000 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
20000000 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
21209000 shares
CY2019Q2 us-gaap Weighted Average Number Of Shares Restricted Stock
WeightedAverageNumberOfSharesRestrictedStock
0 shares
CY2018Q2 us-gaap Weighted Average Number Of Shares Restricted Stock
WeightedAverageNumberOfSharesRestrictedStock
60000 shares
us-gaap Weighted Average Number Of Shares Restricted Stock
WeightedAverageNumberOfSharesRestrictedStock
38000 shares
us-gaap Weighted Average Number Of Shares Restricted Stock
WeightedAverageNumberOfSharesRestrictedStock
62000 shares
CY2019Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2018Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1132000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
761000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1126000 shares
CY2019Q2 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
0 shares
CY2018Q2 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
1052000 shares
us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
0 shares
us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
1386000 shares
CY2019Q2 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
0 shares
CY2018Q2 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
982000 shares
us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
0 shares
us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
835000 shares
CY2019Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19558000 shares
CY2018Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
24438000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20799000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
24618000 shares
CY2019Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7457000 shares
CY2018Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2092000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7243000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1120000 shares
CY2019Q1 lgnd Revenue From Contract With Customers And Gain Loss On Disposition Of Intangible Assets
RevenueFromContractWithCustomersAndGainLossOnDispositionOfIntangibleAssets
827000000.0 USD
CY2019Q1 us-gaap Gain Loss On Disposition Of Intangible Assets
GainLossOnDispositionOfIntangibleAssets
812800000 USD
CY2019Q2 lgnd Short Term Investments Fair Value Disclosure
ShortTermInvestmentsFairValueDisclosure
1059002000 USD
CY2018Q4 lgnd Short Term Investments Fair Value Disclosure
ShortTermInvestmentsFairValueDisclosure
601217000 USD
CY2019Q2 us-gaap Notes Receivable Fair Value Disclosure
NotesReceivableFairValueDisclosure
50116000 USD
CY2018Q4 us-gaap Notes Receivable Fair Value Disclosure
NotesReceivableFairValueDisclosure
46191000 USD
CY2019Q2 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
10260000 USD
CY2018Q4 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
9257000 USD
CY2019Q2 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
1119378000 USD
CY2018Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
656665000 USD
CY2019Q2 us-gaap Other Liabilities Fair Value Disclosure
OtherLiabilitiesFairValueDisclosure
131000 USD
CY2018Q4 us-gaap Other Liabilities Fair Value Disclosure
OtherLiabilitiesFairValueDisclosure
199000 USD
CY2019Q2 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
13208000 USD
CY2018Q4 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
12741000 USD
CY2019Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-1500000 USD
CY2018Q1 lgnd Paymentsto Contingent Value Right Holdersand Other Contingency Payments Investing Activities
PaymentstoContingentValueRightHoldersandOtherContingencyPaymentsInvestingActivities
1000000.0 USD
CY2019Q2 us-gaap Derivative Assets Current
DerivativeAssetsCurrent
14300000 USD
CY2018Q4 lgnd Warrants Settled
WarrantsSettled
525000 shares
CY2019Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
2739643 shares
CY2019Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.200
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.209
CY2018Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.235
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.215
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1300000 shares
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
55.57
CY2019Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
10964000 USD
CY2019Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
989000 USD
CY2019Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
10489000 USD
CY2019Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
11478000 USD
CY2019Q2 lgnd Increase Decrease In Operating Lease Assets
IncreaseDecreaseInOperatingLeaseAssets
6100000 USD
CY2019Q2 lgnd Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
6000000.0 USD
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
785000 USD
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
1880000 USD
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
2175000 USD
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
2214000 USD
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
1939000 USD
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
5349000 USD
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
14342000 USD
CY2019Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
2864000 USD
CY2019Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
11478000 USD
CY2019Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P7Y
CY2019Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.06
CY2019Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
500000 USD
us-gaap Operating Lease Payments
OperatingLeasePayments
1100000 USD
CY2019Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
500000 USD
CY2019Q2 us-gaap Sublease Income
SubleaseIncome
300000 USD
us-gaap Operating Lease Expense
OperatingLeaseExpense
1100000 USD
us-gaap Sublease Income
SubleaseIncome
600000 USD

Files In Submission

Name View Source Status
0000886163-19-000156-index-headers.html Edgar Link pending
0000886163-19-000156-index.html Edgar Link pending
0000886163-19-000156.txt Edgar Link pending
0000886163-19-000156-xbrl.zip Edgar Link pending
exhibit101ligand-amend.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
lgnd-20190630.htm Edgar Link pending
lgnd-20190630.xsd Edgar Link pending
lgnd-20190630_cal.xml Edgar Link unprocessable
lgnd-20190630_def.xml Edgar Link unprocessable
lgnd-20190630_g1.jpg Edgar Link pending
lgnd-20190630_htm.xml Edgar Link completed
lgnd-20190630_lab.xml Edgar Link unprocessable
lgnd-20190630_pre.xml Edgar Link unprocessable
lgnd63019exhibit311.htm Edgar Link pending
lgnd63019exhibit312.htm Edgar Link pending
lgnd63019exhibit321.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
R9999.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending